XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock
Common stock
Additional paid-in capital
Accumulated other comprehensive income / (loss)
Accumulated deficit
Total
Beginning Balance at Dec. 31, 2022     $ 92,933 $ (483) $ (86,567) $ 5,883
Beginning Balance (in shares) at Dec. 31, 2022   771,054        
Stock-based compensation expense     293     293
Issuance of common stock to vendor     55     55
Issuance of common stock to vendor (in shares)   2,937        
Foreign currency translation adjustment       (456)   (456)
Net loss         (2,048) (2,048)
Ending Balance at Mar. 31, 2023     93,281 (939) (88,615) 3,727
Ending Balance (in shares) at Mar. 31, 2023   773,991        
Beginning Balance at Dec. 31, 2022     92,933 (483) (86,567) 5,883
Beginning Balance (in shares) at Dec. 31, 2022   771,054        
Foreign currency translation adjustment           (123)
Net loss           (7,097)
Ending Balance at Sep. 30, 2023     104,571 (606) (93,664) 10,301
Ending Balance (in shares) at Sep. 30, 2023 13,879 876,278        
Beginning Balance at Mar. 31, 2023     93,281 (939) (88,615) 3,727
Beginning Balance (in shares) at Mar. 31, 2023   773,991        
Stock-based compensation expense     119     119
Issuance of preferred stock, net of issuance costs     11,027     11,027
Issuance of preferred stock, net of issuance costs (in shares) 14,149          
Foreign currency translation adjustment       (517)   (517)
Net loss         (2,027) (2,027)
Ending Balance at Jun. 30, 2023     104,427 (1,456) (90,642) 12,329
Ending Balance (in shares) at Jun. 30, 2023 14,149 773,991        
Stock-based compensation expense     119     119
Conversion of Preferred stock into common stock (in shares) (270) 30,859        
Cashless exercise of warrants into common stock     25     25
Cashless exercise of warrants into common stock (in shares)   71,428        
Foreign currency translation adjustment       850   850
Net loss         (3,022) (3,022)
Ending Balance at Sep. 30, 2023     104,571 (606) (93,664) 10,301
Ending Balance (in shares) at Sep. 30, 2023 13,879 876,278        
Beginning Balance at Dec. 31, 2023     104,757 (1,578) (95,066) 8,113
Beginning Balance (in shares) at Dec. 31, 2023 13,765 889,668        
Stock-based compensation expense     107     107
Issuance of stock awards     21     21
Issuance of stock awards (in Shares)   3,400        
Issuance of common stock to vendor     53     53
Issuance of common stock to vendor (in shares)   50,000        
Conversion of Preferred stock into common stock (in shares) (3,817) 436,294        
Exchange of Preferred stock into common stock warrants (in shares) (6,356)          
Deemed dividend on extinguishment of Preferred stock     7,069   (7,094) (25)
Cashless exercise of warrants into common stock (in shares)   388        
Foreign currency translation adjustment       (18)   (18)
Net loss         (1,696) (1,696)
Ending Balance at Mar. 31, 2024     112,007 (1,596) (103,856) 6,555
Ending Balance (in shares) at Mar. 31, 2024 3,592 1,379,750        
Beginning Balance at Dec. 31, 2023     104,757 (1,578) (95,066) 8,113
Beginning Balance (in shares) at Dec. 31, 2023 13,765 889,668        
Foreign currency translation adjustment           281
Net loss           (7,637)
Ending Balance at Sep. 30, 2024     113,374 (1,297) (109,797) 2,280
Ending Balance (in shares) at Sep. 30, 2024 856 1,780,472        
Beginning Balance at Mar. 31, 2024     112,007 (1,596) (103,856) 6,555
Beginning Balance (in shares) at Mar. 31, 2024 3,592 1,379,750        
Stock-based compensation expense     207     207
Issuance of common stock to vendor     48     48
Issuance of common stock to vendor (in shares)   50,000        
Conversion of Preferred stock into common stock (in shares) (2,486) 284,150        
Cashless exercise of warrants into common stock     3     3
Cashless exercise of warrants into common stock (in shares)   8,000        
Fair value of warrants reclassified from liability to equity     700     700
Foreign currency translation adjustment       174   174
Net loss         (3,099) (3,099)
Ending Balance at Jun. 30, 2024     112,965 (1,422) (106,955) 4,588
Ending Balance (in shares) at Jun. 30, 2024 1,106 1,721,900        
Stock-based compensation expense     257     257
Issuance of common stock to vendor     152     152
Issuance of common stock to vendor (in shares)   30,000        
Conversion of Preferred stock into common stock (in shares) (250) 28,572        
Foreign currency translation adjustment       125   125
Net loss         (2,842) (2,842)
Ending Balance at Sep. 30, 2024     $ 113,374 $ (1,297) $ (109,797) $ 2,280
Ending Balance (in shares) at Sep. 30, 2024 856 1,780,472